Company Filing History:
Years Active: 2004
Title: Inventions and Contributions of Catherine Mary Kelly
Introduction
Catherine Mary Kelly, an esteemed inventor based in Athlone, Ireland, has made significant contributions to the field of pharmaceutical formulations. Her innovative approach focuses on enhancing medication delivery and minimizing risks associated with cardiovascular medications.
Latest Patents
Catherine holds a patent for a multiparticulate bisoprolol formulation. This particular formulation is designed for once-daily oral administration, featuring particles that consist of a bisoprolol core or a pharmaceutically acceptable salt. The unique aspect of her invention is the polymeric coating that allows for an initial lag of bisoprolol release in vivo, effectively delaying the release for 4-6 hours post-administration. This innovative approach ensures that therapeutic concentrations of bisoprolol are maintained throughout the 24-hour period. Moreover, the formulation is optimized for night-time dosing, aiming to reduce the risk of acute cardiovascular events during the well-documented high-risk period in the morning.
Career Highlights
Catherine is a key contributor at Biovail Laboratories, Inc., where she works alongside talented colleagues such as Paul Stark and Niall M Fanning. Her expertise and dedication to innovation in drug formulation have positioned her as a leader in her field.
Collaborations
Catherine's collaborative efforts with other professionals at Biovail Laboratories showcase her ability to work effectively as part of a team. Engaging with her coworkers, including Paul Stark and Niall M Fanning, has allowed for the exchange of ideas and expertise, fostering an environment conducive to groundbreaking innovations.
Conclusion
Catherine Mary Kelly's contributions to pharmaceutical innovations, particularly her multiparticulate bisoprolol formulation, exemplify the importance of inventive solutions in healthcare. Her work not only enhances medication administration but also holds significant potential for improving patient outcomes in the field of cardiology.